nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexylcaine—SCN3A—Interaction between L1 and Ankyrins—ANK3—bipolar disorder	0.055	0.0613	CbGpPWpGaD
Hexylcaine—SCN2A—Interaction between L1 and Ankyrins—ANK3—bipolar disorder	0.0528	0.0589	CbGpPWpGaD
Hexylcaine—SCN1A—Interaction between L1 and Ankyrins—ANK3—bipolar disorder	0.051	0.0568	CbGpPWpGaD
Hexylcaine—SCN10A—Interaction between L1 and Ankyrins—ANK3—bipolar disorder	0.051	0.0568	CbGpPWpGaD
Hexylcaine—SCN5A—Interaction between L1 and Ankyrins—ANK3—bipolar disorder	0.0358	0.0399	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—NCAN—bipolar disorder	0.0215	0.024	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—ANK3—bipolar disorder	0.0211	0.0235	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—NCAN—bipolar disorder	0.0207	0.0231	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—ANK3—bipolar disorder	0.0203	0.0226	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—NCAN—bipolar disorder	0.02	0.0223	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—NCAN—bipolar disorder	0.02	0.0223	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—ANK3—bipolar disorder	0.0196	0.0218	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—ANK3—bipolar disorder	0.0196	0.0218	CbGpPWpGaD
Hexylcaine—Diethylpropion—SLC6A3—bipolar disorder	0.019	0.184	CrCbGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—POU3F2—bipolar disorder	0.0177	0.0198	CbGpPWpGaD
Hexylcaine—Methylphenidate—SLC6A3—bipolar disorder	0.0174	0.169	CrCbGaD
Hexylcaine—Dexmethylphenidate—SLC6A3—bipolar disorder	0.0174	0.169	CrCbGaD
Hexylcaine—SCN5A—L1CAM interactions—NCAN—bipolar disorder	0.014	0.0156	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—ANK3—bipolar disorder	0.0137	0.0153	CbGpPWpGaD
Hexylcaine—Cocaine—SLC6A3—bipolar disorder	0.0132	0.128	CrCbGaD
Hexylcaine—Methylphenidate—SLC6A4—bipolar disorder	0.013	0.127	CrCbGaD
Hexylcaine—Dexmethylphenidate—SLC6A4—bipolar disorder	0.013	0.127	CrCbGaD
Hexylcaine—Cocaine—SLC6A4—bipolar disorder	0.00989	0.0959	CrCbGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—NRG1—bipolar disorder	0.00847	0.00945	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—NCAN—bipolar disorder	0.00814	0.00908	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—ANK3—bipolar disorder	0.00798	0.00889	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—NCAN—bipolar disorder	0.00782	0.00872	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—ANK3—bipolar disorder	0.00766	0.00854	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—NCAN—bipolar disorder	0.00754	0.00841	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—NCAN—bipolar disorder	0.00754	0.00841	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—ANK3—bipolar disorder	0.00739	0.00824	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—ANK3—bipolar disorder	0.00739	0.00824	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—GRIN1—bipolar disorder	0.00721	0.00804	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TPH2—bipolar disorder	0.00657	0.00732	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TACR1—bipolar disorder	0.00657	0.00732	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—GRIN1—bipolar disorder	0.00617	0.00688	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—GSK3B—bipolar disorder	0.00615	0.00686	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—INS—bipolar disorder	0.00607	0.00677	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—TRPC3—bipolar disorder	0.00605	0.00674	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—GRIN1—bipolar disorder	0.00593	0.00661	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—NCAN—bipolar disorder	0.00581	0.00648	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—TRPC3—bipolar disorder	0.00581	0.00648	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—GRIN1—bipolar disorder	0.00572	0.00637	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—GRIN1—bipolar disorder	0.00572	0.00637	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ANK3—bipolar disorder	0.00569	0.00635	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—CACNB2—bipolar disorder	0.00562	0.00627	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—TRPC3—bipolar disorder	0.0056	0.00624	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—TRPC3—bipolar disorder	0.0056	0.00624	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—NCAN—bipolar disorder	0.00558	0.00622	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ANK3—bipolar disorder	0.00547	0.0061	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—HTR1A—bipolar disorder	0.00544	0.00606	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—CACNB2—bipolar disorder	0.0054	0.00602	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NCAN—bipolar disorder	0.00538	0.006	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NCAN—bipolar disorder	0.00538	0.006	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TAC1—bipolar disorder	0.00535	0.00597	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—NCAN—bipolar disorder	0.0053	0.00591	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ANK3—bipolar disorder	0.00527	0.00588	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ANK3—bipolar disorder	0.00527	0.00588	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—bipolar disorder	0.00525	0.00585	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—GATA3—bipolar disorder	0.00525	0.00585	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—SNAP25—bipolar disorder	0.00525	0.00585	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—CACNB2—bipolar disorder	0.00521	0.0058	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—CACNB2—bipolar disorder	0.00521	0.0058	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—ANK3—bipolar disorder	0.0052	0.00579	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—CACNA1C—bipolar disorder	0.00514	0.00573	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—NTRK2—bipolar disorder	0.00511	0.0057	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—CACNA1C—bipolar disorder	0.00494	0.00551	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—CACNA1C—bipolar disorder	0.00476	0.00531	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—CACNA1C—bipolar disorder	0.00476	0.00531	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—GRIN1—bipolar disorder	0.0044	0.00491	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—TRPC3—bipolar disorder	0.00431	0.00481	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—GRIN1—bipolar disorder	0.00423	0.00472	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—TRPC3—bipolar disorder	0.00414	0.00462	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—GRIN1—bipolar disorder	0.00408	0.00455	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—GRIN1—bipolar disorder	0.00408	0.00455	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—GRIN2B—bipolar disorder	0.00406	0.00453	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—GRIN1—bipolar disorder	0.00402	0.00448	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CACNB2—bipolar disorder	0.00401	0.00447	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—TRPC3—bipolar disorder	0.004	0.00446	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—TRPC3—bipolar disorder	0.004	0.00446	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—MAOA—bipolar disorder	0.00395	0.00441	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—TRPC3—bipolar disorder	0.00394	0.00439	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—GRIN2B—bipolar disorder	0.0039	0.00435	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CACNB2—bipolar disorder	0.00385	0.0043	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—BDNF—bipolar disorder	0.00381	0.00425	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NCAN—bipolar disorder	0.00378	0.00422	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—GRIN2B—bipolar disorder	0.00376	0.0042	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—GRIN2B—bipolar disorder	0.00376	0.0042	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CACNB2—bipolar disorder	0.00372	0.00414	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CACNB2—bipolar disorder	0.00372	0.00414	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ANK3—bipolar disorder	0.00371	0.00413	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CACNA1C—bipolar disorder	0.00367	0.00409	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—CACNB2—bipolar disorder	0.00366	0.00408	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CACNA1C—bipolar disorder	0.00352	0.00393	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CACNA1C—bipolar disorder	0.0034	0.00379	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CACNA1C—bipolar disorder	0.0034	0.00379	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.00337	0.00375	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—CACNA1C—bipolar disorder	0.00335	0.00373	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.00322	0.00359	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—GRIN2B—bipolar disorder	0.0029	0.00323	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—GRIN1—bipolar disorder	0.00287	0.0032	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—TRPC3—bipolar disorder	0.00281	0.00313	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—GRIN2B—bipolar disorder	0.00279	0.00311	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—GRIN2B—bipolar disorder	0.00269	0.00299	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—GRIN2B—bipolar disorder	0.00269	0.00299	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—GRIN2B—bipolar disorder	0.00265	0.00295	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CACNB2—bipolar disorder	0.00261	0.00291	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CACNA1C—bipolar disorder	0.00239	0.00266	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—GSK3B—bipolar disorder	0.00222	0.00247	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—GSK3B—bipolar disorder	0.00213	0.00238	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—GSK3B—bipolar disorder	0.00206	0.00229	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—GSK3B—bipolar disorder	0.00206	0.00229	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.00191	0.00213	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—GRIN2B—bipolar disorder	0.00189	0.00211	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—GSK3B—bipolar disorder	0.00158	0.00177	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—INS—bipolar disorder	0.00156	0.00174	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—GSK3B—bipolar disorder	0.00152	0.0017	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—INS—bipolar disorder	0.0015	0.00167	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—GSK3B—bipolar disorder	0.00147	0.00164	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—GSK3B—bipolar disorder	0.00147	0.00164	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—INS—bipolar disorder	0.00145	0.00161	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—INS—bipolar disorder	0.00145	0.00161	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—GSK3B—bipolar disorder	0.00145	0.00161	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—GSK3B—bipolar disorder	0.00103	0.00115	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—INS—bipolar disorder	0.00102	0.00113	CbGpPWpGaD
